Correlation Between Taiwan Weighted and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Taiwan Weighted and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taiwan Weighted and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Taiwan Weighted and GeneReach Biotechnology, you can compare the effects of market volatilities on Taiwan Weighted and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taiwan Weighted with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taiwan Weighted and GeneReach Biotechnology.

Diversification Opportunities for Taiwan Weighted and GeneReach Biotechnology

-0.69

Correlation Coefficient

Taiwan Weighted  GeneReach Biotechnology

Excellent diversification

The 3 months correlation between Taiwan and GeneReach is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Taiwan Weighted and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Taiwan Weighted is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taiwan Weighted are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Taiwan Weighted i.e., Taiwan Weighted and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Taiwan Weighted and GeneReach Biotechnology

Assuming the 90 days trading horizon Taiwan Weighted is expected to generate 0.85 times more return on investment than GeneReach Biotechnology. However, Taiwan Weighted is 1.17 times less risky than GeneReach Biotechnology. It trades about 0.1 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.21 per unit of risk. If you would invest  2,185,008  in Taiwan Weighted on September 14, 2024 and sell it today you would earn a total of  119,672  from holding Taiwan Weighted or generate 5.48% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	95.16%
Values	Daily Returns

Taiwan Weighted  vs.  GeneReach Biotechnology

Pair Trading with Taiwan Weighted and GeneReach Biotechnology

The main advantage of trading using opposite Taiwan Weighted and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taiwan Weighted position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Taiwan Weighted and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.